Downstream Processing: Increasing Demand In Biopharmaceuticals Industry

Pune, India, 2020-May-06 — /EPR Network/ —

According to the recent report “Downstream Processing Market by Technique (Separation, Concentration, Purification), Product (Chromatography Column & Resin, Filter, Single use), Application (Mab Production), End User (Contract Manufacturing Organization) – Global Forecast to 2021”. The global downstream processing market is poised to reach USD 22.03 Billion by 2021 from USD 10.32 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021.

Browse in-depth TOC on “Downstream Processing Market”
68 – Tables
40 – Figures
139 – Pages

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=73180930

The growth in the downstream processing market will majorly be driven by the increasing demand for biopharmaceuticals, as downstream processing steps play a significant role in providing pure and quality products. However, the high cost of instruments used in downstream processing is expected to restrain the growth of this market. On the other hand, patent expiration of blockbuster biopharmaceutical products represents significant growth opportunities for the key players in the downstream processing market.

The purification segment accounted for the largest share of the market. This largest share and the high growth is attributed to the need for highly pure biopharmaceutical products to meet the regulatory standards, as downstream purification plays a significant role in enhancing the purity and quality of products aiding the growth of the purification market.

The chromatography columns and resins segment accounted for the largest share of the downstream processing market. Columns and resins are the most important component of a chromatography system and are extensively used in the separation, recovery, and purification of components of a bioactive sample. The constant need for newer and different types of columns and resins is likely to fuel market growth.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=73180930

Geographical Growth Analysis:

North America is the world’s largest pharmaceutical market and a leader in biopharmaceutical research. Rising quality requirements have emphasized the need for advanced bioproduction technology in this region. Asia-Pacific is expected to grow at the highest CAGR during the forecast period. The Asia-Pacific downstream processing market, particularly in China, Japan, India, and South Korea, is expected to witness high growth.